96930 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Keratin; Cytokeratin
COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
#2Platelet lysate-based microparticles, methods and uses thereof
#3Keratin Protein Extracts, Compositions, Methods and Uses Thereof
#4ANTI-TUMOUR RESPONSES TO CYTOKERATINS
#5RECOMBINANT KERATINS AND PRODUCTION THEREOF
#6METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENHANCE THE DROUGHT TOLERANCE ATTRIBUTE OF WHEAT PLANTS
#7METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO PROMOTE THE GROWTH AND DEVELOPMENT OF CORN CROPS
#8METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO IMPROVE THE FERTILIZER USAGE EFFICIENCY IN SOYBEAN
#9METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENHANCE THE YIELD AND QUALITY OF CUCUMBER FRUITS
#10METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENAHNCE THE FLAVOR OF TEA LEAVES
#11METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION UPON COTTON TO ENHANCE DROUGHT-TOLERANCE
#12SKIN MIMICRY COMPOSITIONS AND IMPLANTS
#13Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of KRT5, KRT14, LAMB3, and COL7A1 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-KRT5, or Escherichia coli strain SCS110-AF/VTvaf17-KRT14, or Escherichia coli strain SCS110-AF/VTvaf17-LAMB3, or Escherichia coli strain SCS110-AF/VTvaf17-COL7A1 carrying the gene therapy DNA vector, m
#14Method to Produce Soluble Protein Powder Recovered From Organic Waste
#15DEVICE AND METHOD FOR TISSUE STAINING QUALITY CONTROL
#16METHOD FOR EXTRACTING KERATIN FROM WOOL/NATURAL FIBERS USING IONIC LIQUIDS REINFORCED WITH SONICATION
#17KERATIN BD-6, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#18KERATIN HYDROLYSATE HIGH IN FREE AMINO ACIDS AND HIGH IN FREE TYROSINE, METHOD FOR OBTAINING AND USING SAME FOR ANIMAL FEED AND PLANT NUTRITION
#19Keratin Filament Networks
#20KERATIN BD-11, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#21Collagen-localized immunomodulatory molecules and methods thereof
#22KERATIN BD-10, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#23Keratin BD-4, preparation method, and pharmaceutical composition and use thereof
#24EPITOPES
#25INTERMEDIATE FILAMENT-DERIVED PEPTIDES AND THEIR USES
#26Synthesis of Non-Native Proteins in Bombyx Mori by Modifying Sericin Expression
#27Protein Fiber Production Method
#28Compositions and Methods for Inhibiting Intermediate Filament Tetramerization
#29Keratin hydrolysate for oral cosmetic use
#30METHODS AND USES FOR KERATIN EMPLOYING PROTEASES
#31KERATIN HYDROLYSATE FOR ORAL COSMETIC USE
#32Polypeptide solution, production method for polypeptide fiber, and artificial polypeptide
#33COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
#34Methods for extracting keratin proteins
#35ENGINEERED TREATMENTS FOR HAIR REPAIR AND LONG-LASTING COLOR RETENTION
#36Coatings and biomedical implants formed from keratin biomaterials
#37Method of preparing ultra-low molecular weight keratin peptide
#38Keratin allyl thioether three-dimensional cell culture system
#39METHODS AND USES FOR KERATIN HYDROLYSIS
#40Keratin-based hydrogels
#41ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF
#42METHODS FOR IDENTIFYING PATIENTS RESPONSIVE TO ANTI-PD-L1 ANTIBODY THERAPY
#43BIOSORBENTS FOR REMOVAL OF CONTAMINANTS FROM WASTE/OIL SAND PROCESS-AFFECTED WATER (OSPW) AND CONSOLIDATION OF OIL SANDS TAILINGS
#44Keratin nanomaterials and methods of production
#45Method for continuous production of degradation product of water-insoluble polymeric compound
#46Ultra-small apoB-containing particles and methods of use thereof
#47Anti-microbial peptides and methods of use thereof
#48Method for inhibiting HIV replication in mammal and human cells
#49Method of preparing a keratin-based biomaterial and keratin-based biomaterial formed thereof
#50Fractionation of charged keratin
#51Antiviral compositions
#52METHOD
#53Ultra-small ApoB-containing particles and methods of use thereof
#54Methods for extracting keratin proteins
#55Anti-microbial peptides and methods of use thereof
#56Method for inhibiting HIV replication in mammal and human cells
#57Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same
#58Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)
#59Hair treatment composition with naturally - derived peptide identical to human hair
#60Controlled delivery system
#61Hydratable Keratin Compositions
#62Clotting and healing compositions containing keratin biomaterials
#63Bioactive keratin peptides
#64REAGENT COMPRISING PRIMER FOR DETECTION OF mRNA FOR CYTOKERATIN-7
#65KERATIN DERIVATIVES AND METHODS OF MAKING THE SAME
#66Method for separating keratinous proteins from materials
#67Method for producing reduced keratin, reduced cuticle protein and mixture thereof
#68KERATIN DERIVATIVES AND METHODS OF MAKING THE SAME
#69Coatings and biomedical implants formed from keratin biomaterials
#70Polytetrafluoroethylene binding peptides and methods of use
#71Nucleic acid constructs
#72Process For Producing Solubilized Keratin
#73Modified KAP polypeptides and use thereof
#74Repeat sequence protein polymer active agent congjugates, methods and uses
#75Hair keratin-associated proteins
#76Production of soluble keratin derivaties